Rapidly discovers and develops novel small molecule drugs using genetics, AI/ML, and synthetic biology to source chemistry from the human body.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Empress Therapeutics applies genetics, AI/ML, and synthetic biology to rapidly discover and develop new small molecule drugs by sourcing chemistry from within the human body. Their Chemilogics™ platform enables the predictable generation and validation of millions of novel chemical compounds for drug discovery in a fraction of the traditional time using genetic data and co-evolution.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Investors
Flagship Pioneering
Empress Therapeutics Valuations & Financials
View real-time NPM data on Empress Therapeutics stock including daily Empress Therapeutics stock price estimates, valuation history, and historical share price information. Access Empress Therapeutics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Empress Therapeutics pricing across six independent market signals. Looking for private company due diligence data sources on Empress Therapeutics? Get in touch to learn more.
Similar Companies
like Empress Therapeutics
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Strada
Enterprise Software
Delivers a platform that automates billing and revenue workflows while improving financial visibility and operational efficiency.
LinearB
Enterprise Software
Develops analytics software that improves engineering team productivity by optimizing workflows and software delivery performance.
Hadrius
FinTech
Develops technology that applies data science and machine learning to analyze markets and support investment decision making.
TrueAccord
FinTech
Drives debt recovery through automated, personalized digital engagement and self‑serve repayment options.
Trainual
Enterprise Software
Cloud-based platform streamlines employee training and onboarding by enabling businesses to create and manage standardized training workflows.
Full Harvest
Climate & Sustainability
Digitizing produce commerce to enable sale of surplus and imperfect harvests, turning would-be waste into value.
ellipse
FinTech
Develops dynamic security code technology for payment cards to enhance e-commerce transaction safety, extending EMV protocols without batteries.
Olio
Healthcare & Life Sciences
Provides a platform that connects care teams and streamlines coordination to improve patient outcomes through shared data and collaboration.
FAQ
We have answers
Empress Therapeutics stock does not trade on public stock exchanges. Empress Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Empress Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Empress Therapeutics Stock does not trade on public stock exchanges. In order to sell Empress Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Empress Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Empress Therapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Empress Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Empress Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Empress Therapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Empress Therapeutics is a private company and has not had an IPO. There is currently no Empress Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Empress Therapeutics IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
